Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marvin Jens

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
EMBO Molecular Medicine|September 4, 2013
Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulationYongbo Wang, Andreas Gogol-Döring, Hao Hu, et al.
Nature|March 1, 2013
Circular RNAs are a large class of animal RNAs with regulatory potencySebastian Memczak, Marvin Jens, Antigoni Elefsinioti, et al.
Molecular Cell|March 28, 2017
Translation of CircRNAsNagarjuna Reddy Pamudurti, Osnat Bartok, Marvin Jens, et al.
The Journal of Clinical Investigation|June 25, 2014
RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processingHenrike Maatz, Marvin Jens, Martin Liss, et al.
Molecular Cell|April 30, 2015
Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically ExpressedAgnieszka Rybak-Wolf, Christin Stottmeister, Petar Glažar, et al.
Frontiers in Immunology|December 15, 2025
Investigating genetic modifications to enhance L1CAM-CAR T cell migration in solid tumors in a 3D bioprinted neuroblastoma modelLena Andersch, Laura Grunewald, Maria Stecklum, et al.
Cancers|February 13, 2026
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma CellsMarius Ludwig, Kerstin Ahrens, Annika Winkler, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 29, 2025
EPICYCLE: A confirmatory preclinical study of the anti-rhabdomyosarcoma efficacy of BET bromodomain and cyclin-dependent kinase 9 inhibitorsBernhard Haller, Günther H S Richter, Marco Wachtel, et al.
Nature Communications|December 9, 2025
Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumorsMichael Launspach, Julia Macos, Shoaib Afzal, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
EMBO Molecular Medicine|September 4, 2013
Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulationYongbo Wang, Andreas Gogol-Döring, Hao Hu, et al.
Nature|March 1, 2013
Circular RNAs are a large class of animal RNAs with regulatory potencySebastian Memczak, Marvin Jens, Antigoni Elefsinioti, et al.
Molecular Cell|March 28, 2017
Translation of CircRNAsNagarjuna Reddy Pamudurti, Osnat Bartok, Marvin Jens, et al.
The Journal of Clinical Investigation|June 25, 2014
RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processingHenrike Maatz, Marvin Jens, Martin Liss, et al.
Molecular Cell|April 30, 2015
Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically ExpressedAgnieszka Rybak-Wolf, Christin Stottmeister, Petar Glažar, et al.
Frontiers in Immunology|December 15, 2025
Investigating genetic modifications to enhance L1CAM-CAR T cell migration in solid tumors in a 3D bioprinted neuroblastoma modelLena Andersch, Laura Grunewald, Maria Stecklum, et al.
Cancers|February 13, 2026
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma CellsMarius Ludwig, Kerstin Ahrens, Annika Winkler, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 29, 2025
EPICYCLE: A confirmatory preclinical study of the anti-rhabdomyosarcoma efficacy of BET bromodomain and cyclin-dependent kinase 9 inhibitorsBernhard Haller, Günther H S Richter, Marco Wachtel, et al.
Nature Communications|December 9, 2025
Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumorsMichael Launspach, Julia Macos, Shoaib Afzal, et al.
Pageof 2